Several studies demonstrated that downregulation of METTL3 in psoriasis-lesional tissues and METTL3-mediated m6A modification promoted the proliferation of keratinocytes and inflammation (Xian et al., 2022; Wang, Huang & Jin, 2022). The gene discussed is METTL3; the disease is psoriasis.